应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02171 科济药业-B
未开盘 07-22 16:08:56
4.670
+0.140
+3.09%
最高
4.840
最低
4.530
成交量
165.10万
今开
4.530
昨收
4.530
日振幅
6.84%
总市值
26.88亿
流通市值
26.88亿
总股本
5.76亿
成交额
780.73万
换手率
0.29%
流通股本
5.76亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科济药业-B盘中异动 早盘快速拉升5.08%报4.760港元
自选股智能写手 · 07-22 09:56
科济药业-B盘中异动 早盘快速拉升5.08%报4.760港元
科济药业-B(02171)股价上升5.238%,现价港币$4.42
阿斯达克财经 · 07-17
科济药业-B(02171)股价上升5.238%,现价港币$4.42
科济药业-B盘中异动 急速拉升5.00%报4.410港元
自选股智能写手 · 07-17
科济药业-B盘中异动 急速拉升5.00%报4.410港元
科济药业-B盘中异动 大幅下挫5.16%报4.040港元
自选股智能写手 · 07-15
科济药业-B盘中异动 大幅下挫5.16%报4.040港元
科济药业-B(02171)股价下跌5.164%,现价港币$4.04
阿斯达克财经 · 07-15
科济药业-B(02171)股价下跌5.164%,现价港币$4.04
科济药业-B07月11日主力资金流入38万元 连续3日加仓
自选股智能写手 · 07-11
科济药业-B07月11日主力资金流入38万元 连续3日加仓
科济药业-B盘中异动 股价大涨5.00%报4.200港元
自选股智能写手 · 07-11
科济药业-B盘中异动 股价大涨5.00%报4.200港元
科济药业-B盘中异动 急速下跌5.02%
自选股智能写手 · 07-08
科济药业-B盘中异动 急速下跌5.02%
科济药业-B盘中异动 急速上涨6.00%
自选股智能写手 · 07-03
科济药业-B盘中异动 急速上涨6.00%
非执行董事郭华清增持科济药业-B(02171)8万股 每股作价4.95港元
智通财经 · 07-02
非执行董事郭华清增持科济药业-B(02171)8万股 每股作价4.95港元
科济药业-B07月02日获主力加仓262万元 环比增加555.00%
自选股智能写手 · 07-02
科济药业-B07月02日获主力加仓262万元 环比增加555.00%
科济药业-B盘中异动 急速下跌5.21%
自选股智能写手 · 07-02
科济药业-B盘中异动 急速下跌5.21%
非执行董事郭华清增持科济药业-B(02171)5万股 每股作价4.96港元
智通财经 · 06-28
非执行董事郭华清增持科济药业-B(02171)5万股 每股作价4.96港元
科济药业-B(02171)6月28日斥资72万港元回购15万股
智通财经 · 06-28
科济药业-B(02171)6月28日斥资72万港元回购15万股
非执行董事郭华清增持科济药业-B(02171)4.25万股 每股作价4.96港元
智通财经 · 06-27
非执行董事郭华清增持科济药业-B(02171)4.25万股 每股作价4.96港元
科济药业-B盘中异动 急速跳水5.24%
自选股智能写手 · 06-27
科济药业-B盘中异动 急速跳水5.24%
【港股通】科济药业(02171):主要股东已增持190万股股份 公司已回购398万股
金吾财讯 · 06-27
【港股通】科济药业(02171):主要股东已增持190万股股份 公司已回购398万股
科济药业(02171.HK)主要股东年度内累计增持190.4万股
阿斯达克财经 · 06-27
科济药业(02171.HK)主要股东年度内累计增持190.4万股
科济药业-B(02171)获益杰一致行动集团增持190.35万股
智通财经 · 06-27
科济药业-B(02171)获益杰一致行动集团增持190.35万股
非执行董事郭华清增持科济药业-B(02171)5万股 每股作价为5.6港元
智通财经网 · 06-25
非执行董事郭华清增持科济药业-B(02171)5万股 每股作价为5.6港元
暂无数据
公司概况
公司名称:
科济药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
科济药业控股有限公司是一家主要从事创新嵌合抗原受体(CAR)T 细胞疗法发现、开发及销售业务的中国投资控股公司。该公司的疗法用于治疗血液恶性肿瘤和实体瘤。该公司已开发升级版靶向B细胞成熟抗原(BCMA)的CAR-T产品CT053。CT053为其的唯一核心候选产品。该公司在中国和美国开展业务。
发行价格:
--
{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科济药业-B","latestPrice":4.67,"timestamp":1721635736030,"preClose":4.53,"halted":0,"volume":1651000,"delay":0,"floatShares":575675415,"shares":575675415,"eps":-1.4385717,"marketStatus":"未开盘","marketStatusCode":0,"change":0.14,"latestTime":"07-22 16:08:56","open":4.53,"high":4.84,"low":4.53,"amount":7807310,"amplitude":0.068433,"askPrice":4.7,"askSize":2500,"bidPrice":4.67,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":-1.438571660187657,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1623945600000,"adjPreClose":4.53,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.832011320536276,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171/tweets","defaultTab":"tweets","newsList":[{"id":"2453785665","title":"科济药业-B盘中异动 早盘快速拉升5.08%报4.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453785665","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453785665?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:56","pubTimestamp":1721613395,"startTime":"0","endTime":"0","summary":"2024年07月22日早盘09时56分,科济药业-B股票出现异动,股价大幅上涨5.08%。截至发稿,该股报4.760港元/股,成交量13.1万股,换手率0.02%,振幅5.08%。资金方面,该股资金流入41.471万港元,流出10.2105万港元。科济药业-B股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,华领医药-B、盛禾生物-B、科济药业-B涨幅较大,振幅较大的相关个股有华领医药-B、维亚生物、巨子生物,振幅分别为15.70%、7.07%、6.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722095635941f9006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722095635941f9006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2452900228","title":"科济药业-B(02171)股价上升5.238%,现价港币$4.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2452900228","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452900228?lang=zh_cn&edition=full","pubTime":"2024-07-17 14:04","pubTimestamp":1721196240,"startTime":"0","endTime":"0","summary":"[上升股]科济药业-B(02171) 股价在下午02:04比前收市价上升5.238%,现股价为港币$4.42。至目前为止,今日最高价为$4.42,而最低价为$4.16。总成交量为156.2万股,总成交金额为港币$676.315万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407171194/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2452900153","title":"科济药业-B盘中异动 急速拉升5.00%报4.410港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452900153","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452900153?lang=zh_cn&edition=full","pubTime":"2024-07-17 14:03","pubTimestamp":1721196194,"startTime":"0","endTime":"0","summary":"2024年07月17日下午盘14时03分,科济药业-B股票出现波动,股价快速上涨5.00%。截至发稿,该股报4.410港元/股,成交量155.85万股,换手率0.27%,振幅5.95%。资金方面,该股资金流入367.601万港元,流出249.299万港元。科济药业-B股票所在的生物技术行业中,整体涨幅为1.26%。其相关个股中,百奥赛图-B、金斯瑞生物科技、泰格医药涨幅较大,振幅较大的相关个股有维亚生物、盛禾生物-B、百奥赛图-B,振幅分别为16.35%、16.10%、10.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171403149681d804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171403149681d804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","02171","BK1585"],"gpt_icon":0},{"id":"2451665904","title":"科济药业-B盘中异动 大幅下挫5.16%报4.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451665904","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451665904?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:19","pubTimestamp":1721009954,"startTime":"0","endTime":"0","summary":"2024年07月15日早盘10时19分,科济药业-B股票出现波动,股价快速下挫5.16%。截至发稿,该股报4.040港元/股,成交量42.8004万股,换手率0.07%,振幅5.63%。资金方面,该股资金流入42.6145万港元,流出110.035万港元。科济药业-B股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,金斯瑞生物科技、永泰生物-B、歌礼制药-B涨幅较大,振幅较大的相关个股有金斯瑞生物科技、方达控股、来凯医药-B,振幅分别为17.80%、10.47%、9.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715101914aef9a67b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715101914aef9a67b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"2451665242","title":"科济药业-B(02171)股价下跌5.164%,现价港币$4.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2451665242","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451665242?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:19","pubTimestamp":1721009940,"startTime":"0","endTime":"0","summary":"[下跌股]科济药业-B(02171) 股价在上午10:19比前收市价下跌5.164%,现股价为港币$4.04。至目前为止,今日最高价为$4.28,而最低价为$4.04。总成交量为42.8万股,总成交金额为港币$177.817万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240715500/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1585","BK1161","BK1587","02171","BK1574"],"gpt_icon":0},{"id":"2450380736","title":"科济药业-B07月11日主力资金流入38万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450380736","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450380736?lang=zh_cn&edition=full","pubTime":"2024-07-11 16:16","pubTimestamp":1720685802,"startTime":"0","endTime":"0","summary":"07月11日, 科济药业-B股价涨2.50%,报收4.10元,成交金额923万元,换手率0.39%,振幅7.75%,量比1.34。科济药业-B今日主力资金净流入38万元,连续3日净流入,上一交易日主力净流入57万元,今日环比减少33.33%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为27.27%,平均涨幅为0.91%。该股近5个交易日下跌6.82%,主力资金累计净流入223万元;近20日主力资金累计净流入3197万元,其中净流入天数为15日。该股主力净额占比0.02%,港股市场排名239/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111617099f3329fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407111617099f3329fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1585","BK1587","02171"],"gpt_icon":0},{"id":"2450987242","title":"科济药业-B盘中异动 股价大涨5.00%报4.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450987242","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450987242?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:57","pubTimestamp":1720663072,"startTime":"0","endTime":"0","summary":"2024年07月11日早盘09时57分,科济药业-B股票出现波动,股价大幅拉升5.00%。截至发稿,该股报4.200港元/股,成交量56.3万股,换手率0.10%,振幅6.00%。资金方面,该股资金流入67.0455万港元,流出116.192万港元。科济药业-B股票所在的生物技术行业中,整体涨幅为0.98%。其相关个股中,盛禾生物-B、昭衍新药、荣昌生物涨幅较大,振幅较大的相关个股有科伦博泰生物-B、圣诺医药-B、方达控股,振幅分别为16.80%、9.48%、8.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110957529681bc35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110957529681bc35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1574","BK1587","BK1161","02171"],"gpt_icon":0},{"id":"2449715550","title":"科济药业-B盘中异动 急速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449715550","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449715550?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:58","pubTimestamp":1720403928,"startTime":"0","endTime":"0","summary":"2024年07月08日早盘09时58分,科济药业-B股票出现波动,股价快速下跌5.02%。截至发稿,该股报4.160港元/股,成交量31.05万股,换手率0.05%,振幅3.88%。科济药业-B股票所在的生物技术行业中,整体跌幅为0.88%。科济药业-B公司简介:科济药业控股有限公司是一家主要从事创新嵌合抗原受体T 细胞疗法发现、开发及销售业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708095849aef85459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708095849aef85459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1161","02171","BK1585"],"gpt_icon":0},{"id":"2448668110","title":"科济药业-B盘中异动 急速上涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448668110","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448668110?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:31","pubTimestamp":1719970303,"startTime":"0","endTime":"0","summary":"2024年07月03日早盘09时31分,科济药业-B股票出现异动,股价快速上涨6.00%。科济药业-B股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,药明巨诺-B、盛禾生物-B、科济药业-B涨幅较大,振幅较大的相关个股有盛禾生物-B、昭衍新药、歌礼制药-B,振幅分别为7.03%、3.36%、3.26%。消息层面,截至09时31分,科济药业-B股票正面舆情新闻比例50%。增持后,郭华清最新持股数目为2.18亿股股份,好仓比例由37.80%升至37.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703093143aef7aa02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703093143aef7aa02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02171","BK1161","BK1587","BK1585"],"gpt_icon":0},{"id":"2448132320","title":"非执行董事郭华清增持科济药业-B(02171)8万股 每股作价4.95港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448132320","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448132320?lang=zh_cn&edition=full","pubTime":"2024-07-02 18:52","pubTimestamp":1719917529,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,6月28日,非执行董事郭华清增持科济药业-B(02171)8万股,每股作价为4.95港元,总金额39.6万港元。增持后最新持股数目约为2.17亿股,持股比例为37.81%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1585","BK1161","02171"],"gpt_icon":0},{"id":"2448821481","title":"科济药业-B07月02日获主力加仓262万元 环比增加555.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448821481","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448821481?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:15","pubTimestamp":1719908113,"startTime":"0","endTime":"0","summary":"07月02日, 科济药业-B股价跌6.25%,报收4.50元,成交金额963万元,换手率0.36%,振幅7.92%,量比0.99。科济药业-B今日主力资金净流入262万元,连续3日净流入,上一交易日主力净流入40万元,今日环比增加555.00%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为30.00%,平均涨幅为0.91%。该股近5个交易日下跌7.60%,主力资金累计净流入201万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入3025万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702161527956522e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702161527956522e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","02171","BK1574","BK1161","BK1587"],"gpt_icon":0},{"id":"2448109908","title":"科济药业-B盘中异动 急速下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448109908","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448109908?lang=zh_cn&edition=full","pubTime":"2024-07-02 11:18","pubTimestamp":1719890289,"startTime":"0","endTime":"0","summary":"2024年07月02日早盘11时18分,科济药业-B股票出现异动,股价快速下跌5.21%。截至发稿,该股报4.550港元/股,成交量100.5万股,换手率0.17%,振幅6.67%。科济药业-B股票所在的生物技术行业中,整体跌幅为0.73%。其相关个股中,歌礼制药-B、诺诚健华、金斯瑞生物科技涨幅较大,振幅较大的相关个股有帝王国际投资、东曜药业-B、来凯医药-B,振幅分别为14.06%、13.24%、11.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702111809941f3051&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702111809941f3051&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2446505779","title":"非执行董事郭华清增持科济药业-B(02171)5万股 每股作价4.96港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446505779","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446505779?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:42","pubTimestamp":1719574938,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,6月27日,非执行董事郭华清增持科济药业-B(02171)5万股,每股作价为4.96港元,总金额24.8万港元。增持后最新持股数目约为2.176亿股,持股比例为37.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2446142505","title":"科济药业-B(02171)6月28日斥资72万港元回购15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446142505","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446142505?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:39","pubTimestamp":1719574780,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2024年6月28日斥资72万港元回购15万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1161","BK1587","02171","BK1574"],"gpt_icon":0},{"id":"2446566535","title":"非执行董事郭华清增持科济药业-B(02171)4.25万股 每股作价4.96港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446566535","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446566535?lang=zh_cn&edition=full","pubTime":"2024-06-27 19:28","pubTimestamp":1719487714,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,6月26日,非执行董事郭华清增持科济药业-B(02171)4.25万股,每股作价为4.96港元,总金额21.08万港元。增持后最新持股数目约为2.175亿股,持股比例为37.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02171","BK1161","BK1585","BK1574"],"gpt_icon":0},{"id":"2446269377","title":"科济药业-B盘中异动 急速跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446269377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446269377?lang=zh_cn&edition=full","pubTime":"2024-06-27 13:16","pubTimestamp":1719465383,"startTime":"0","endTime":"0","summary":"2024年06月27日下午盘13时16分,科济药业-B股票出现异动,股价大幅跳水5.24%。科济药业-B股票所在的生物技术行业中,整体跌幅为1.66%。消息层面,截至13时16分,科济药业-B股票正面舆情新闻比例77.78%。《非执行董事郭华清增持科济药业-B5万股 每股作价为5.6港元》资讯为影响科济药业-B的重要信息。增持后最新持股数目约为2.174亿股,持股比例为37.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627131623941f1b11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627131623941f1b11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","02171","BK1161","BK1585"],"gpt_icon":0},{"id":"2446321515","title":"【港股通】科济药业(02171):主要股东已增持190万股股份 公司已回购398万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446321515","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446321515?lang=zh_cn&edition=full","pubTime":"2024-06-27 09:14","pubTimestamp":1719450870,"startTime":"0","endTime":"0","summary":"金吾财讯 | 科济药业(02171)公布,董事会于近日获益杰生物告知,益杰一致行动集团已于本年度内直至2024年6月25日(收市后)购买合共190.35万股股份,占已发行股份总数约0.33%。于增持股份后,益杰一致行动集团持有2.17亿股股份,占已发行股份总数约37.78%。另外,截至2024年6月25日收市后,公司已购回合共398.55万股股份,占已发行股份总数约0.69%。购回股份所用资金来自非IPO募集资金,其中包括业务发展收入、利息收入及其他补贴。公司可在满足合规要求的前提下,从维持公司市值的角度进一步购回股份。公司当前无意进行将触发香港收购及合并守则项下责任的股份购回。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1939380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1161","07226","HSTECH","02171","BK1587","BK1574","YANG","HSCEI"],"gpt_icon":0},{"id":"2446326456","title":"科济药业(02171.HK)主要股东年度内累计增持190.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446326456","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446326456?lang=zh_cn&edition=full","pubTime":"2024-06-27 08:41","pubTimestamp":1719448860,"startTime":"0","endTime":"0","summary":"科济药业(02171.HK) 公布,其主要股东益杰生物及其一致行动集团已于本年度内直至今年6月25日购买合共190.35万股股份,占已发行股份总数约0.33%。于增持股份后,益杰一致行动集团于公司的持股量由37.45%增至37.78%。此外,截至今年6月25日收市后,公司已购回合共398.55万股股份,占已发行股份总数约0.69%。购回股份所用资金来自非IPO募集资金,其中包括业务发展收入、利息收入及其他补贴。(jl/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-06-26 16:25。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20211223145802440_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20211223145802440_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1359532/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1587","BK1585","BK1161","02171"],"gpt_icon":0},{"id":"2446232349","title":"科济药业-B(02171)获益杰一致行动集团增持190.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446232349","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446232349?lang=zh_cn&edition=full","pubTime":"2024-06-27 08:12","pubTimestamp":1719447152,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B 发布公告,董事会于近日获主要股东益杰生物告知,益杰一致行动集团已于本年度内直至2024年6月25日(收市后)购买合共190.35万股股份,占已发行股份总数约0.33%。于增持股份后,益杰一致行动集团持有2.17亿股股份,占已发行股份总数约37.78%。董事会认为,增持股份彰显主要股东对公司的前景及增长潜力充满信心以及对公司长期投资价值的认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","BK1161","02171","BK1585"],"gpt_icon":0},{"id":"2446632845","title":"非执行董事郭华清增持科济药业-B(02171)5万股 每股作价为5.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446632845","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446632845?lang=zh_cn&edition=full","pubTime":"2024-06-25 20:30","pubTimestamp":1719318600,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,6月20日,非执行董事郭华清增持科济药业-B(02171)5万股,平均每股作价为5.6港元,总金额28万港元。增持后最新持股数目约为2.174亿股,持股比例为37.78%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-06-25/doc-inazyeac1027933.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-06-25/doc-inazyeac1027933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02171","BK1574","BK1585","BK1587"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":0.128},{"period":"1month","weight":-0.157},{"period":"3month","weight":-0.0043},{"period":"6month","weight":-0.1019},{"period":"1year","weight":-0.5535},{"period":"ytd","weight":-0.2815}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科济药业控股有限公司是一家主要从事创新嵌合抗原受体(CAR)T 细胞疗法发现、开发及销售业务的中国投资控股公司。该公司的疗法用于治疗血液恶性肿瘤和实体瘤。该公司已开发升级版靶向B细胞成熟抗原(BCMA)的CAR-T产品CT053。CT053为其的唯一核心候选产品。该公司在中国和美国开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.177045},{"month":2,"riseRate":0.666667,"avgChangeRate":0.218959},{"month":3,"riseRate":0,"avgChangeRate":-0.160429},{"month":4,"riseRate":0,"avgChangeRate":-0.124967},{"month":5,"riseRate":0.666667,"avgChangeRate":0.010432},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.000476},{"month":7,"riseRate":0.5,"avgChangeRate":0.029335},{"month":8,"riseRate":0.666667,"avgChangeRate":0.153185},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.047024},{"month":10,"riseRate":0.666667,"avgChangeRate":0.068937},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.035529},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.177104}],"exchange":"SEHK","name":"科济药业-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科济药业-B,02171,科济药业-B股票,科济药业-B股票老虎,科济药业-B股票老虎国际,科济药业-B行情,科济药业-B股票行情,科济药业-B股价,科济药业-B股市,科济药业-B股票价格,科济药业-B股票交易,科济药业-B股票购买,科济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}